Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Model Using FmOI for Timing of Ovulation Trigger in Controlled Ovarian Stimulation
jRCT1031240409Recruiting
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of follitropin delta, follitropin alfa and relugolix in female infertility, sponsored by none. Primary endpoint: Concordance between actual and predicted number of mature oocytes. Started Oct 2024; status: recruiting.
02
Drugs
follitropin deltafollitropin alfarelugolix
03
Conditions
female infertility
Beyond the preview
Go deeper on jRCT1031240409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240409.